Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BA.5.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BE.1.4.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BE.1.4.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.1.4.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BE.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BE.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
CH.2ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
CH.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
CH.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.53ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.53ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.5.2.53SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.53SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.53NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BA.5.2.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.6ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
BL.6ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BL.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BL.6SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BL.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.6NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BL.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.53 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.53 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21977.3China
AY.53 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.10ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.36.10ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
B.1.36.10SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.36.10SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-22844.7China
B.1.36.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.599ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.599ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
B.1.599SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.599SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-18276.9China
B.1.599NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.128ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.128ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used